ArticleDiabetology & metabolic syndrome2026
Metformin versus DPP-4 inhibitors and risk of parkinsonism in type 2 diabetes: an active-comparator cohort study with a landmark design.
Mingyang Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.